Improved methods and commercialization of native mass spectrometry by capillary vibrating sharp-edge spray ionization (cvssi)
Ended Project Grant Awarded Last action
- Award ID
- R41GM142379
- Recipient
-
Invibragen Inc. UEI H6U3AQDR4367
- Awarding agency
-
National Institute of General Medical Sciences
National Institutes of Health, Department of Health and Human Services
- Obligated
- $747,163
Award facts
- Assistance listing
- 93.859 Biomedical Research and Research Training
- Completion date
- Funding
-
- $490,710.91 Federal
- $256,452.00 Non-federal
- Place of performance
- West Virginia, USA
Award details come from USAspending.gov.
Description
- Abstract
- /summary over the last 20 years, mass spectrometry (MS) instrumentation has advanced at a remarkable clip. Improvements in ION focusing, mass analyzer, and ION detection regions have greatly enabled the study of protein molecules in their native state (native MS). One area that has remained relatively constant is the ionization source where nanoelectrospray ionization (nesi) has remained the most sensitive means to produce the large biomolecules of interest. A severe drawback of nesi for native MS is that IT suffers from stability issues when operated in negative ION mode. This primarily results from the earlier onset of the corona discharge in negative ION mode which abrogates ION production. The result of this limitation is to drastically reduce the utility of native MS as >104 proteins exhibit PI values below 6. This has implications for the study of protein structures important to human health ranging from therapeutic molecules to those associated with disease onset and progression. Recently, the research group of prof. Peng LI at west virginia university developed a new ionization technique termed vibrating sharp-edge spray ionization (vssi). The approach has recently been demonstrated to provide a 10× to 100× boost in ionization performance compared with state-of-the-art approaches operated in negative ION mode. Here, we will leverage the power of the new approach to provide a prototype ionization source which will consistently provide 100× signal enhancements in negative ION mode and 10× improvement in positive ION mode. These leaps in ionization efficiency will unlock the door to high-efficiency native MS experiments especially in negative ION mode. The result will be to enable human health researchers to characterize the structures of many important proteins that have heretofore remained largely inaccessible.
Transactions
| Action | Federal | Non-federal | Date |
|---|---|---|---|
| Amendment | -$22,193 | $0 | |
| Amendment | $256,452 | $0 | |
| Original award | $256,452 | $256,452 |
Quick answers
Who received award R41GM142379?
R41GM142379 was awarded to Invibragen Inc. by National Institute of General Medical Sciences (National Institutes of Health) on September 1, 2021.
How much is award R41GM142379 worth?
$747,163 has been obligated on R41GM142379: $490,711 in federal funding and $256,452 in non-federal funding.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award